Iodoxamic acid

Chemical compound
  • V08AC01 (WHO)
Identifiers
  • 3-{1-[(3-carboxy-2,4,6-triiodophenyl)carbamoyl]-3,6,9,12-tetraoxapentadecan-15-amido}-2,4,6-triiodobenzoic acid
CAS Number
  • 31127-82-9
PubChem CID
  • 35740
DrugBank
  • DB13539
ChemSpider
  • 32877
UNII
  • NS1Y283HW4
KEGG
  • D01312
ChEMBL
  • ChEMBL1201324
CompTox Dashboard (EPA)
  • DTXSID4057710 Edit this at Wikidata
ECHA InfoCard100.045.875 Edit this at WikidataChemical and physical dataFormulaC26H26I6N2O10Molar mass1287.925 g·mol−13D model (JSmol)
  • Interactive image
  • OC(=O)c(c1I)c(I)cc(I)c1NC(=O)CCOCCOCCOCCOCCC(=O)Nc(c2I)c(I)cc(I)c2C(=O)O

Iodoxamic acid (trade name Endobil) is an organoiodine compound used as a radiocontrast agent.[1] It features both a high iodine content as well as several hydrophilic groups.

See also

  • Iodinated contrast

References

  1. ^ Mützel W, Taenzer V, Wolf R (1976). "Biotransformation of ioglycamic acid, iodoxamic acid and iotroxic acid in man". Investigative Radiology. 11 (6): 598–601. doi:10.1097/00004424-197611000-00018. PMID 1036733.
  • v
  • t
  • e
Contrast media (V08)
X-ray and CT
Iodinated,
Water soluble
Nephrotropic,
high osmolar
Nephrotropic,
low osmolar
Hepatotropic
Iodinated,
Water insoluble
Non-iodinated
MRI
Paramagnetic
Superparamagnetic
Other
Ultrasound
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e